CME Group Inc. (NASDAQ:CME) Shares Bought by Marcum Wealth LLC

Marcum Wealth LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,707 shares of the financial services provider’s stock after purchasing an additional 94 shares during the period. Marcum Wealth LLC’s holdings in CME Group were worth $532,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Second Half Financial Partners LLC acquired a new position in shares of CME Group in the fourth quarter worth about $2,737,000. Sapient Capital LLC acquired a new position in shares of CME Group in the fourth quarter worth about $1,823,000. Raymond James Financial Services Advisors Inc. raised its position in shares of CME Group by 2.3% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 1,041,526 shares of the financial services provider’s stock worth $224,230,000 after acquiring an additional 23,340 shares during the period. Bluefin Capital Management LLC acquired a new position in shares of CME Group in the fourth quarter worth about $2,891,000. Finally, Alaska Permanent Fund Corp raised its position in shares of CME Group by 81.4% in the first quarter. Alaska Permanent Fund Corp now owns 44,534 shares of the financial services provider’s stock worth $9,588,000 after acquiring an additional 19,985 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Trading Down 1.3 %

Shares of CME stock traded down $2.61 during trading hours on Monday, hitting $197.22. The company had a trading volume of 2,133,193 shares, compared to its average volume of 1,960,977. The company’s fifty day moving average is $198.38 and its 200 day moving average is $207.01. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.01. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The stock has a market capitalization of $71.01 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 6.27 and a beta of 0.52.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the prior year, the business posted $2.30 EPS. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. Research analysts expect that CME Group Inc. will post 9.8 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were issued a dividend of $1.15 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.33%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Ratings Changes

A number of research analysts have weighed in on CME shares. Piper Sandler decreased their price objective on shares of CME Group from $235.00 to $225.00 and set an “overweight” rating for the company in a research report on Thursday, July 25th. Barclays boosted their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Rosenblatt Securities reissued a “sell” rating and issued a $187.00 price target (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on shares of CME Group from $195.00 to $193.00 and set a “hold” rating for the company in a research note on Thursday, July 25th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $212.64.

Insiders Place Their Bets

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other CME Group news, Director Daniel R. Glickman sold 650 shares of the stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the sale, the director now directly owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares in the company, valued at $1,399,936.72. The disclosure for this sale can be found here. Insiders have sold a total of 14,290 shares of company stock worth $2,957,300 in the last ninety days. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.